(Q43937874)

English

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis (English)

1 reference

Europe PubMed Central

28 November 2017

Walter P Maksymowych

1

object named as

Walter P Maksymowych

1 reference

Europe PubMed Central

28 November 2017

author name string

Gian S Jhangri

2

1 reference

Europe PubMed Central

28 November 2017

Avril A Fitzgerald

3

1 reference

Europe PubMed Central

28 November 2017

Sharon LeClercq

4

1 reference

Europe PubMed Central

28 November 2017

Peter Chiu

5

1 reference

Europe PubMed Central

28 November 2017

Alex Yan

6

1 reference

Europe PubMed Central

28 November 2017

Kenneth J Skeith

7

1 reference

Europe PubMed Central

28 November 2017

Stephen L Aaron

8

1 reference

Europe PubMed Central

28 November 2017

Joanne Homik

9

1 reference

Europe PubMed Central

28 November 2017

Paul Davis

10

1 reference

Europe PubMed Central

28 November 2017

Dale Sholter

11

1 reference

Europe PubMed Central

28 November 2017

Anthony S Russell

12

1 reference

Europe PubMed Central

28 November 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

28 November 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

28 November 2017

46

1 reference

Europe PubMed Central

28 November 2017

3

1 reference

Europe PubMed Central

28 November 2017

766-773

1 reference

Europe PubMed Central

28 November 2017

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Pre-ankylosing spondylitis. Histopathological report

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates.

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Bisphosphonates: pharmacology, mechanisms of action and clinical uses

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

The pharmacology of bisphosphonates and new insights into their mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Sustained response to intravenous alendronate in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

The association of bone marrow lesions with pain in knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Magnetic resonance imaging of sacroiliac joint inflammation

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy.

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Inhibition of antigen-presenting cell function by alendronate in vitro

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

The acute-phase response after bisphosphonate administration

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

The effect of alendronate on cytokine production, adhesion molecule expression, and transendothelial migration of human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FART.10139

21 January 2018

Identifiers

10.1002/ART.10139

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43937874&oldid=2104516228"